Hover to zoom
GLP-1 & MetabolicSynthetic long-acting amylin analog
Cagrilintide
$99.99
10 mgCagrilintide is a synthetic, long-acting analog of amylin — a pancreatic peptide co-secreted with insulin that signals through amylin receptor complexes formed by the calcitonin receptor and receptor-activity-modifying proteins.
Its stability makes it useful in laboratory research examining amylin receptor pharmacology over extended experimental windows, often alongside incretin peptides for comparison.
Research areas
Amylin receptor signalingCalcitonin receptor biologyMetabolic pathway researchPreclinical research
Form: Lyophilized (freeze-dried)
- Compound class
- Synthetic long-acting amylin analog
- Research category
- GLP-1 & Metabolic
- SKU
- NVR-CAGRILINTIDE-10MG
- Alternate name
- Cagri
- Appearance
- White to off-white lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
10 mg$99.99$10.00/mg
1
$99.99per 10 mg$10.00/mg
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know
More detail on Cagrilintide.
Analytical values reflect per-lot documentation and appear once a batch is released.
Compound
Native amylin aggregates readily and has a short half-life, which historically limited its use as a laboratory reagent. Cagrilintide was designed with substitutions and acylation that improve solubility and duration, giving researchers a more tractable amylin receptor agonist. Investigations focus on receptor selectivity across amylin receptor subtypes, comparison with calcitonin-receptor agonists, and how amylin-pathway signaling interacts with incretin-pathway signaling in preclinical models. This material is supplied as a research reagent only.
Peptide class
Synthetic long-acting amylin analog
Mechanism (research context)
As an amylin analog, cagrilintide is studied for interaction with amylin and calcitonin receptor complexes. Preclinical literature examines its effects on gastric emptying models and satiety-signaling pathways.
Why it is studied
Cagrilintide is a defined-sequence tool for investigators exploring long-acting amylin receptor agonism, particularly in combination-peptide research alongside GLP-1 analogs such as semaglutide.
Current areas of research
Amylin receptor signalingCalcitonin receptor biologyMetabolic pathway researchPreclinical research
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
Scientific background
Amylin is a 37-amino-acid peptide co-secreted with insulin by pancreatic β-cells. Its analogs have been an active area of metabolic research since the 1990s.
Cagrilintide was developed as a long-acting analog with modifications that extend its plasma half-life relative to native amylin.
Contemporary research pairs cagrilintide with GLP-1 analogs to explore combination-peptide metabolic effects in preclinical models.
Related
View all →Related research materials
Cagrilintide / Semaglutide
5/5 mg
Research blend pairing an amylin analog with a GLP-1 receptor agonist for combined-pathway studies.
$119.99
DetailsHGH Fragment 176-191
5 mg
Unmodified C-terminal growth-hormone fragment used in comparative adipose-tissue research.
$69.99
DetailsRetatrutide
4 strengths available
Triple agonist peptide targeting GIP, GLP-1, and glucagon receptors in preclinical metabolic research.
Up to 64% lower per mg
from$59.99
DetailsCagrilintide
10 mg · $99.99